Research Article

Related GMR Articles

04/13/2010
Bladder cancer; CCR2-V64I; Chemokines; MCP-1 A-2518G; Polymorphism

Chemokines are potent proinflammatory cytokines that are implicated in numerous inflammatory diseases. Proinflammatory gene polymorphisms lead to variations in the production and concentration of inflammatory proteins. We investigated a possible association between polymorphisms in chemokine and chemokine receptor genes (MCP-1 A-2518G and CCR2-V64I) and bladder cancer risk. Genotypes were ... more

K.F. Narter; B. Agachan; S. Sozen; Z.B. Cincin; T. Isbir
05/06/2013
Bladder cancer; KEGG pathway; T1-T2; Ta-T1; Tumor grades

Bladder cancer is a highly heterogeneous neoplasm. We examined the gene expression profile in 3 bladder cancer stages (Ta, T1, T2) using expression microarray analysis of 40 bladder tumors. Differentially expressed genes were found by the t-test, with ANXA5, ATP6V1B2, CTGF, GEM, IL13RA1, and LCP1); 5 genes were up-regulated at the Ta-T1 ... more

Z.Q. Fang; W.D. Zang; R. Chen; B.W. Ye; X.W. Wang; S.H. Yi; W. Chen; F. He; G. Ye
04/02/2013
Bladder cancer; Recurrence; Survivin; Vascular endothelial growth factor

Survivin and vascular endothelial growth factor (VEGF) are newly discovered tumor markers closely correlated with bladder cancer. We analyzed the expression of survivin and VEGF in paraffin-embedded tumor tissues from 78 patients with bladder transitional cell carcinoma (BTCC) using an immunohistochemistry method. Normal bladder mucosae from 10 non-BTCC cases were also included as a ... more

Y.W. Sun; Q. Xuan; Q.A. Shu; S.S. Wu; H. Chen; J. Xiao; P. Xiang; Y.P. Zhu; F.L. Wang; S.T. Zhao
04/02/2013
Apoptosis; Bladder cancer; Gene expression; RT-PCR

We examined the expression of anti-apoptotic genes (XIAP and Bcl-2) and apoptotic genes (cytochrome c, caspase-9, Apaf-1) in tissue samples of patients with superficial bladder cancer. Thirty-two bladder cancer tissue samples (8 papillary urothelial neoplasm of low malignant potential, 10 low-grade, and 14 high-grade) and 8 normal bladder ... more

D.F. Barione; F.S.N. Lizarte; P.C. Novais; C.A.M. de Carvalho; F.C.B. Valeri; F.M. Peria; H.F. de Oliveira; D.L. Zanette; W.A. Silva; A.J. Cologna; R.B. Reis; S. Tucci; A.C.P. Martins; D.P.C. Tirapelli; L.F. Tirapelli
09/26/2012
Bladder cancer; Genetic susceptibility; hOGG1; Meta-analysis; Polymorphism

The functional polymorphism Ser326Cys (rs1052133) in the human 8-oxoguanine DNA glycosylase (hOGG1) gene has been implicated in bladder cancer risk. However, reports of this association between the Ser326Cys polymorphism and bladder cancer risk are conflicting. In order to help clarify this relationship, we made a meta-analysis of seven case-control studies, summing 2521 cases ... more

D.Y. Zhong; H.Y. Chu; M.L. Wang; L. Ma; D.N. Shi; Z.D. Zhang
11/28/2014
Bladder cancer; Gene polymorphism; Meta-analysis; XRCC1 Arg399Gln

We examined whether the X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism is a risk factor for bladder cancer by conducting a meta-analysis. We searched the Pubmed and Embase databases for study retrieval. This meta-analysis examined 16 case-control studies, including 892 prostate cancer cases and 1020 healthy controls. Meta-analysis results based on these studies ... more

L.M. Dong; X.Y. Zhang; H. Teng; M.S. Li; P. Wang
07/25/2014
Bladder cancer; Meta-analysis; PSCA; rs2294008 (C>T) polymorphism

Several published articles have evaluated the association between the prostate stem cell antigen (PSCA) rs2294008 (C>T) polymorphism and bladder cancer risk, but the results remain inconclusive. In order to derive a more precise estimation of the association, we performed a meta-analysis of four case-control studies that included 9617 cases and 16,323 controls. Odds ratios (ORs) and 95 ... more

Y. Zhao; Z.L. Gui; S. Liao; F. Gao; Y.Z. Ge; R.P. Jia
04/30/2014
Bladder cancer; Control mechanism; Genes; Module network

Bladder cancer is a common cancer worldwide and its incidence continues to increase. There are approximately 261,000 cases of bladder cancer resulting in 115,000 deaths annually. This study aimed to integrate bladder cancer genome copy number variation information and bladder cancer gene transcription level expression data to construct a causal-target module network of the range of ... more

J.M. Wang; Y.Q. Wang; Z.L. Gao; J.T. Wu; B.K. Shi; C.C. Yu
04/27/2015
Bladder cancer; CYFRA21-1; Meta-analysis

The proteolytic region of cytokeratin-19, referred to as CYFRA21-1, is a soluble molecule present in the serum and other body fluids, and is considered a tumor marker in several neoplastic diseases. To examine whether urinary or serum samples containing CYFRA21-1 can be used as biomarkers for bladder cancer, we conducted a comprehensive meta-analysis of 3 case-control studies. In all ... more

L.I. Kuang; W.J. Song; H.M. Qing; S. Yan; F.L. Song
02/13/2015
B7-H1 expression; Bladder cancer; Meta-analysis

B7 homolog 1 (B7-H1), which is also known as programmed death-L1, is an important member of the B7/CD28 costimulatory factor superfamily, which are emerging as important mediators of various host immune responses. B7-H1 is differentially expressed in various cell subsets and to different extents in human and murine cells. Human B7-H1 is constitutively expressed at low levels in dendritic ... more

Y.U. Wang; A.N.G. Liu; S.H.A.N. Zhao

Pages